IL10 and periodontitis: Although these data, again, can reinforce the pro-inflammatory feature of diabetes, the lack of significant difference in the IFN-γ/IL-10 ratio 30 days after the periodontitis treatment ends (T1) can demonstrate that this procedure was able to impact this ratio, apparently in the non-diabetic group.